Evidence map›Paper›PMID 29867149›Full record

ArticleNature communications2018

Laminin heparin-binding peptides bind to several growth factors and enhance diabetic wound healing.

Jun Ishihara, Ako Ishihara, Kazuto Fukunaga, Koichi Sasaki, Michael J V White, Priscilla S Briquez, Jeffrey A Hubbell

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 92 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
92citing papers in PubMed, 2 pooled it
14.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

92 citing papers in PubMed, 2 syntheses or guidelines pooled it, 230 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Review
  10. Review
  11. Article
  12. Review
  13. Article
  14. Review
  15. Article
  16. Review
  17. TheeLife · 2025
    Article
  18. Review
  19. Article
  20. Review

32 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Jun IshiharaInstitute for Molecular Engineering, University of Chicago, Chicago, IL, 60637, USA.ORCID http://orcid.org/0000-0002-9083-9859
Ako IshiharaInstitute for Molecular Engineering, University of Chicago, Chicago, IL, 60637, USA.
Kazuto FukunagaInstitute for Molecular Engineering, University of Chicago, Chicago, IL, 60637, USA.
Koichi SasakiInstitute for Molecular Engineering, University of Chicago, Chicago, IL, 60637, USA.
Michael J V WhiteInstitute for Molecular Engineering, University of Chicago, Chicago, IL, 60637, USA.
Priscilla S BriquezInstitute for Molecular Engineering, University of Chicago, Chicago, IL, 60637, USA.
Jeffrey A HubbellInstitute for Molecular Engineering, University of Chicago, Chicago, IL, 60637, USA. jhubbell@uchicago.edu.
University of Chicago · USKyushu University · JPTokyo Institute of Technology · JP

Funding

Engineering Growth Factor-ECM Interactions to Heal Chronic Wounds in Type 1 DiabetesDP3DK108215 · NIDDK · UNIVERSITY OF CHICAGO · PI HUBBELL, JEFFREY A. · 2015 to 2015
$1.5M
NIDDK NIH HHS DP3 DK108215
6 · The paper itself

Abstract

Laminin, as a key component of the basement membrane extracellular matrix (ECM), regulates tissue morphogenesis. Here, we show that multiple laminin isoforms promiscuously bind to growth factors (GFs) with high affinity, through their heparin-binding domains (HBDs) located in the α chain laminin-type G (LG) domains. These domains also bind to syndecan cell-surface receptors, promoting attachment of fibroblasts and endothelial cells. We explore the application of these multifunctional laminin HBDs in wound healing in the type-2 diabetic mouse. We demonstrate that covalent incorporation of laminin HBDs into fibrin matrices improves retention of GFs and significantly enhances the efficacy of vascular endothelial cell growth factor (VEGF-A165) and platelet-derived growth factor (PDGF-BB) in promoting wound healing in vivo, under conditions where the GFs alone in fibrin are inefficacious. This laminin HBD peptide may be clinically useful by improving biomaterial matrices as both GF reservoirs and cell scaffolds, leading to effective tissue regeneration.

Indexed as

AnimalsBinding SitesCells, CulturedDiabetes Mellitus, Type 2FibrinHeparinHumansIntercellular Signaling Peptides and ProteinsLamininMaleMice, Inbred C57BLPeptidesProtein BindingSkinWound HealingFibrinHeparinIntercellular Signaling Peptides and ProteinsLamininPeptides

Identifiers

PMID29867149
PMCPMC5986797
OpenAlexW2805260639

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.